CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 11 enrolled
Drug / intervention
0.25% Marcaine at 2ml/hr and pain medications +1 moredrug
Likely dose
0.25% Marcaine at 2ml/hr and pain medicationsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03476811
NCT03476811Phase 2Completed
CompareCT.gov

Postoperative subQ Pain Control for Spinal Fusion Surgery

University of Arizona·interventional·Posted Mar 26, 2018·Updated May 26, 2022

In Brief

A Phase 2 clinical trial evaluating 0.25% Marcaine at 2ml/hr and pain medications and Placement of OnQ Drug pump for Spine Fusion and 2 related conditions. Completed, enrolled 11 participants across 1 site.

Detailed Summary

Post-operative pain following lumbar spine fusion is frequently difficult to manage and can lead to increased doses of opiate pain medications to control pain. In this study, the use of subcutaneous local anesthesia will be studied to determine its efficacy at reducing post-operative pain following spinal fusion surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpine Fusion, Surgery, Pain, Postoperative
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedMar 26, 2018
Enrollment StartFeb 9, 2018
Primary CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 8.3 years ago

Interventions

0.25% Marcaine at 2ml/hr and pain medicationsdrug

Subcutaneous pain control with OnQ Subcutaneous Drug pump

Placement of OnQ Drug pumpdevice

Subcutaneous placement of OnQ drug pump with normal saline infusion